2025-2034 Cloud Genomics Market Outlook: Key Drivers, Emerging Challenges, and Strategic Insights

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Cloud Genomics Industry Market Size Be by 2025?
In recent times, the cloud genomics market has exponentially expanded in size. From 2024 to 2025, we anticipate its growth from $3.17 billion to $3.91 billion, which amounts to a compound annual growth rate (CAGR) of 23.3%. Factors contributing to this growth over the historic period include the emergence of biobank initiatives, an increase in cancer genomics research, growing usage of cloud solutions for data storage, heightened adoption of cloud computing within the healthcare sector, and rising interest in the management of population health.

What's the Long-Term Growth Forecast for the Cloud Genomics Market Size Through 2029?
Projected to experience remarkable expansion in the coming years, the cloud genomics market size is anticipated to reach $8.93 billion by 2029, growing at a compound annual growth rate (CAGR) of 23.0%. This predicted surge during the forecast period can be ascribed to the development of precision medicine, growth in genetic disorders, increased public cognizance about genetic health threats, enhanced availability of direct-to-consumer genomic testing, and escalated government backing for genomic studies. Key trends to watch in the forecast period encompass progress in sequencing technologies, the amalgamation of artificial intelligence, alliances between public and private entities, seamless integration with electronic health records, and significant advancements in bioinformatics tools.

View the full report here:
https://www.thebusinessresearchcompany.com/report/cloud-genomics-global-market-report

What Are the Key Growth Drivers Fueling the Cloud Genomics Market Expansion?
The cloud genomics market is projected to experience substantial growth owing to increased investments in genomics research. Genomics research is a comprehensive study of an organism's entire DNA sequence, exploring gene functionality, interactions, and their influence on biological processes. This research's funding is intensifying due to its potential to facilitate personalized medicine, which offers more precise diagnosis and treatments tailored to a person's genetic composition. As a result, these investments prompt a surge in cloud genomics usage since the large volume of genomic data produced necessitates scalable, efficient, and economic cloud infrastructure for storage and analysis. For example, the Department of Health and Social Care, a UK government department, reported in December 2022 that the government had pledged an investment of £105 million to expedite the diagnosis of rare genetic disorders in newborns. This effort aims to deliver vital, possibly life-saving treatments for many infants by supporting research aimed at progressing genomic healthcare through patient DNA study. Consequently, the elevated investment in genomics research is catalyzing the expansion of the cloud genomics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28176&type=smp

What Are the Key Trends Driving Cloud Genomics Market Growth?
Top industry players in the cloud genomics market are turning their focus towards creating enhanced solutions, such as software accelerators, to streamline the creation and implementation of intricate applications. Software accelerators are applications or tools that can bolster the speed and productivity of software applications, by optimizing both data processing and computational tasks. For example, in January 2023, a bioinformatics firm based in the US, QIAGEN Digital Insights (QDI), introduced QIAGEN CLC Genomics Workbench Premium. This innovative development addresses the issue of data analysis slowdown in next-generation sequencing (NGS) by offering considerably sped-up analysis to review and understand whole genome sequencing (WGS), whole exome sequencing (WES), and comprehensive panel sequencing data. The software includes a feature called 'LightSpeed' technology, a software accelerator that swiftly turns raw FASTQ sequencing data from any paired-end short-read platform into comprehensible VCF-format genetic variant lists. It has the capability to evaluate a complete human genome at 34x coverage within 25 minutes using a standard computer and a 50x whole exome in just 90 seconds in common cloud environments. This technology allows labs to carry out whole genome sequencing for roughly $1 per genome and whole exome sequencing for only a few cents per exome, utilizing cloud infrastructure. Furthermore, QIAGEN CLC LightSpeed can be effectively run on current local hardware while still maintaining high-speed performance.

How Is the Cloud Genomics Market Segmented?
The cloud genomics market covered in this report is segmented as

1) By Component: Software, Hardware, Services
2) By Deployment Mode: Public Cloud, Private Cloud, Hybrid Cloud
3) By Application: Clinical Diagnostics, Drug Discovery And Development, Personalized Medicine, Research, Other Applications
4) By End-User: Hospitals And Clinics, Research And Academic Institutions, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:
1) By Software: Genomic Data Analysis Software, Bioinformatics Tools, Laboratory Information Management Systems (LIMS), Data Visualization Software, Workflow Automation Software
2) By Hardware: High-Performance Computing (HPC) Systems, Servers, Storage Systems, Sequencing Instruments, Networking Equipment
3) By Services: Cloud Storage And Data Management Services, Data Analysis And Interpretation Services, Consulting And Implementation Services, Software-As-A-Service (SaaS) Solutions, Maintenance And Support Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=28176&type=smp

Which Companies Are Leading the Charge in Cloud Genomics Market Innovation?
Major companies operating in the cloud genomics market are Microsoft Corp., Amazon Web Services Inc., F. Hoffmann-La Roche Ltd., IBM Corporation, Oracle Corporation, Thermo Fisher Scientific Inc., Illumina Inc., PerkinElmer Inc., Qiagen N.V., Element Biosciences Inc., Human Longevity Inc., Seven Bridges Genomics, DNAnexus Inc., Lifebit Biotech Ltd., Fabric Genomics Inc., PierianDx Inc., Veritas Genetics Inc., WuXi, NantOmics LLC, Saphetor SA, Nebula Genomics, Gene by Gene Ltd., Nucleome Therapeutics.

Which Regions Are Leading the Global Cloud Genomics Market in Revenue?
North America was the largest region in the cloud genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cloud genomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=28176

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.